Are Decentralized Clinical Trials at Risk, or Ready?
50% of clinical trials will be hybrid or decentralized by 2024 according to E&Y.
The increasing use of decentralized trial components is incredibly welcome news for our patients, but it also magnifies the operational complexity and risks for trial sponsors.
Check out the latest White Paper by the ArcheMedX team and discover if your decentralized clinical trials are at Risk, or Ready.
Learn how to recognize and mitigate the increased risks when home health staff, caregivers, and patients play more active roles across the study without the same level of training and oversight provided at traditional study sites.
